(IN BRIEF) AstraZeneca's Supplemental Biologics License Application (sBLA) seeking approval for a self- or caregiver-administered option for FluMist Quadrivalent, a…
(IN BRIEF) Evonik's life sciences division, Nutrition & Care, has introduced GMP (Good Manufacturing Practices) production of PhytoSquene®, a non-animal-derived…
(IN BRIEF) BioNTech SE is set to reveal its financial results for the third quarter of 2023 on November 6th,…
(IN BRIEF) AstraZeneca and Daiichi Sankyo have received European Union (EU) approval for their drug Enhertu as a monotherapy for…
(IN BRIEF) ViiV Healthcare, a global specialist HIV company, will present 23 abstracts at the 19th Annual European AIDS Conference…
(IN BRIEF) Soliris (eculizumab) has received approval in China for the treatment of adult patients with neuromyelitis optica spectrum disorder…
(IN BRIEF) Merck, a leading science and technology company, has announced its expectation to return to organic sales growth in…
(IN BRIEF) Servier, a global pharmaceutical group, has partnered with Owkin, a biotech company specializing in AI-driven drug discovery and…
(IN BRIEF) Merck, a leading science and technology company, is set to present 28 abstracts at the 2023 European Society…
(IN BRIEF) BioNTech will be presenting updates on multiple programs across its oncology pipeline at the European Society for Molecular…